BioSpace News Archive

Large increase in the number of patients treated with weekly and monthly Buvidal® for opioid dependence

Sensor Electronic Technology, Inc., a leading global innovator of deep UV LED products and technology, announced that it has been successful in achieving 99.9% sterilization of coronavirus in 30 seconds.

RhoVac AB announces, on April 2 2020, that the company is now seeing signs of delays in the ongoing clinical phase IIb study with the drug candidate RV001 in prostate cancer, due to the Covid-19 pandemic.

The COVID-19 pandemic has brought unprecedented challenges upon the global community and the many healthcare providers who are caring for patients.

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Axxam S.p.A., a leading discovery biology company, announced the signing of a license agreement granting Axxam access to ERS Genomics’ CRISPR-Cas9 patent portfolio, to support Axxam’s integrated discovery service platform.

Circadia Health announces $3 million in medical devices and services towards COVID-19 relief efforts across the globe.

RedHill to promote Movantik® in the U.S. to expanded call points, including gastroenterologists, primary care physicians and additional specialists, along with Talicia® and Aemcolo®

First Positive Head-to-Head Phase 3 Trial Comparing a Single-Agent Cancer Medicine to Standard of Care Chemotherapy as First-line Treatment for MSI-H or dMMR Colorectal Cancer

Applied Therapeutics Inc. announced that a COVID-19 IND has been opened with the FDA for AT-001, a novel potent Aldose Reductase inhibitor in global Phase 3 development for Diabetic Cardiomyopathy.

BioCryst Pharmaceuticals, Inc. announced the appointment of Anthony Doyle as senior vice president and chief financial officer..